NeuralBase AI Ltd. Submits HeartEase App for Google Play Store Review

NeuralBase AI Ltd., operating under its enterprise brand BMP AI, has reached a significant milestone by submitting its HeartEase mobile application for review on the Google Play Store. This step is crucial in making the app available to Android users globally, offering them advanced, AI-powered health and wellness support focused on heart health. The HeartEase app is designed to provide real-time insights and personalized guidance, marking a significant advancement in accessible healthcare technology.

Following the Android release, NeuralBase plans to proceed with the final testing and submission of the iOS version to the Apple App Store. This strategy ensures that HeartEase will be accessible to a broad global audience, regardless of their preferred mobile platform. Vighnesh Dobale, CEO of NeuralBase AI, expressed enthusiasm about bringing HeartEase to the Android community and highlighted the company's broader vision to make AI-driven healthcare support universally available.

The submission of the HeartEase app to the Google Play Store is a testament to NeuralBase's commitment to innovation in the healthcare sector. By leveraging AI technology, the company aims to empower individuals with tools for better heart health management. Additional information about NeuralBase AI Ltd. can be found by visiting https://www.neuralbase.ai or through the U.S. Securities and Exchange Commission's website at https://www.sec.gov.

This development is not just a milestone for NeuralBase but also represents a leap forward in making healthcare technology more accessible and personalized. The HeartEase app's potential to provide real-time, AI-powered insights could significantly impact how individuals monitor and manage their heart health, offering a glimpse into the future of digital healthcare solutions.